with slide / Treatment with the angiotensin II receptor blocker candesartan within the first week of an acute ischemic stroke reduced mortality and vascular events by almost 50% in patients who ...

Objectives: In this prospective, double-blind, placebo-controlled study we observed the influence of treatment with candesartan 8mg on restenosis rates after stent implantation into the femoral ...

Treatment with candesartan can increase regression of retinopathy in type 2 diabetes and reduce incidence of retinopathy in type 1 diabetes. These are among the conclusions of the DIRECT studies ...

The vascular protective effects of placebo, candesartan (1 mg kg−1 per day) monotherapy, candesartan (1 mg kg−1 per day) and amlodipine (1 mg kg−1 per day) combination therapy, and ...

Data from a registry of patients with HF have shown more favorable mortality rates at 1 and 5 years for candesartan when compared with losartan. Study investigators analyzed patients (n=5,139 ...

A total of 409 participants were randomly assigned to candesartan, and 400 to placebo. Data on 772 participants (391 in the candesartan group and 381 in the placebo group; mean age, 48.5 years; 59 ...

A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia , 2013; DOI: 10.1177 ...

Candesartan Medication Information. Learn everything you need to know about Candesartan-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.